CC-11006 - Inxight Drugs
U.S. Department of Health & Human Services National Institutes of Health NCATS Return Home Inxight Drugs
SHOW SMILES / InChI SHOW STEREO... HIDE STEREO...
SUBSTANCE RECORD 6DC9826KIM CC-11006 NIH NCATS PRIVACY ACT ACCESSIBILITY DISCLAIMER HHS VULNERABILITY DISCLOSURE For language access assistance, contact the NCATS Public Information Officer National Center for Advancing Translational Sciences (NCATS), 6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966 version 1.1
- Home
- Browse Drugs
- US Approved Drugs
- Marketed Drugs
- Investigational Drugs
- All Substances
- Search
- Structure Search
- Sequence Search
- Downloads
- About
Details
Stereochemistry | RACEMIC |
Molecular Formula | C18H17N3O5 |
Molecular Weight | 355.3447 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
- Structure Search
SMILES
O=C(NCC1=CC=CC2=C1C(=O)N(C3CCC(=O)NC3=O)C2=O)C4CC4InChI
InChIKey=ZBXHNCURDISBRO-UHFFFAOYSA-N InChI=1S/C18H17N3O5/c22-13-7-6-12(16(24)20-13)21-17(25)11-3-1-2-10(14(11)18(21)26)8-19-15(23)9-4-5-9/h1-3,9,12H,4-8H2,(H,19,23)(H,20,22,24) HIDE SMILES / InChIApproval Year
Unknown139594Name | Type | Language | ||
---|---|---|---|---|
| Code | English | ||
| Systematic Name | English | ||
| Systematic Name | English | ||
| Systematic Name | English |
Code System | Code | Type | Description | |
---|---|---|---|---|
| 444287-44-9 Created by admin on Fri Dec 15 16:21:30 GMT 2023 , Edited by admin on Fri Dec 15 16:21:30 GMT 2023 | PRIMARY | ||
| C101370 Created by admin on Fri Dec 15 16:21:30 GMT 2023 , Edited by admin on Fri Dec 15 16:21:30 GMT 2023 | PRIMARY | ||
| 934481-60-4 Created by admin on Fri Dec 15 16:21:30 GMT 2023 , Edited by admin on Fri Dec 15 16:21:30 GMT 2023 | NO STRUCTURE GIVEN | ||
| 6DC9826KIM Created by admin on Fri Dec 15 16:21:30 GMT 2023 , Edited by admin on Fri Dec 15 16:21:30 GMT 2023 | PRIMARY | ||
| 10155135 Created by admin on Fri Dec 15 16:21:30 GMT 2023 , Edited by admin on Fri Dec 15 16:21:30 GMT 2023 | PRIMARY |
Từ khóa » Cc-11006
-
A Phase I, Open-Label, Dose-Escalation Study Of CC-11006 In ...
-
CC 11006 - AdisInsight - Springer
-
Definition Of Immunomodulatory Agent CC-11006 - NCI Drug ...
-
Cc-11006 | C18H17N3O5 - ChemSpider
-
N-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)methyl ...
-
Immunomodulatory Agent CC-11006 - The Titi Tudorancea Bulletin
-
Rachmaninoff Symphony No2 LP William Steinberg Command CC ...
-
10-K
-
Deuterating Chiral Centers Stabilizes Thalidomide Analogs - C&EN
-
[PDF] Pharmacology Review(s) - CPY Document - FDA
-
Glutarimide - An Overview | ScienceDirect Topics
-
CC 11006 SD Rachmaninoff Symphony 2 Pittsburgh SO William ...
-
Structures Of Thalidomide, Pomalidomide, Lenalidomide, And ...